Stifel: Downgrades Bolt Biotherapeutics (BOLT.US) from buy to hold, with target price adjusted from $6.00 to $1.50.
Stifel：下调Bolt Biotherapeutics(BOLT.US)评级，由买入调整至持有评级, 目标价由6.00美元调整至1.50美元。
Stifel: Bolt Biotherapeutics (BOLT.US) rating was downgraded from buy to hold, and the target price was adjusted from $6.00 to $1.50.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.